Name: Future Potential for Current Medications
Uploaded: 2022-05-10T18:23:00.000Z
Description: Is timing everything? Chrysalyne D. Schmults, MD, FAAD looks to a future where clinicians have a better understanding of the “how” and “when” of using hedgehog inhibitors and anti-PD1 medication. Here are the questions she’d like to see answered in upcoming research.

Acne 

Actinic Keratosis 

Aesthetics

Anti-Aging

Biologic Treatments for Moderate to Severe Atopic Dermatitis 

Atopic Dermatitis 

COVID-19

Drug Watch

Dry Cracked Skin

Hidradenitis Suppurativa

Impetigo

Inflamed Skin

Melasma

NP and PA

Pediatric Dermatology

Pigmentary Disorders 

Practice Management 

Precision Medicine and Biologics

Emerging Therapies Plaque Psoriasis

Treatments for Plaque Psoriasis 

Psoriasis 

Psoriatic Arthritis 

Rare Disease

Rosacea 

Skin Cancer (Nonmelanoma)

Skin Cancer

Surgery

Vitiligo

Wound Care

News

Media

2 Minute Drill

Around the Practice

Between The Lines

Case Based Peer Perspective

DermView

Editorial Board News

Expert Interviews

Expert Perspectives

Fellows Face Off

Frontline Forum

Inside the Clinic

Medical World News

Partner Perspectives

Patient Perspectives

Podcasts

Readout360

Recognize and Refer

Viewpoints

Webinars

Conferences

Conference Coverage

Conference Listing

Publication

Dermatology Times

CME/CE

Resources

DermIQ

Image IQ

Interactive Tools

Job Board

Polls

Editorial Advisory Board

Partnerships

Subscribe

Print Subscription

eNewsletter

Articles

Understanding these relationships is crucial for developing effective clinical management strategies for patients with AD, according to a recent literature review.

Exploring the Relationship Between AD, Psychological Stress, Sleep Disturbances, and Salivary Biomarkers

 and joined the MJH Life Sciences team in June 2022. She attended Otterbein University in Westerville, Ohio, and earned a Bachelor of Arts degree in literary studies with minors in creative writing and film studies. Prior to health care news, Kaitlyn worked in industrial marketing. She enjoys cooking, reading, and tending to her house plants. 

2023 was full of advancements in both medical and cosmetic dermatology, and 2024 is shaping up to be just as exciting. 

Renata Block, PA-C, Reflects on Dermatology Innovations in 2023 

Ahead of 2024, Dermatology Times wants to know what conferences and meetings you plan to attend in early 2024. Share your thoughts with us by December 10.

What Conferences Are You Planning to Attend in Quarter 1 of 2024?

and joined the MJH Life Sciences team in February 2023. She attended Kent State University and earned a Bachelor of Science degree in journalism with minors in public relations and creative writing. She enjoys making and listening to music, reading, and spending time with her cats, Astrid and Marceline.

A review examined the treatment landscape of BCC, particularly in the realm of photodynamic therapy.

Combination Techniques With Photodynamic Therapy Show Promise in Treatment of Pigmented Basal Cell Carcinomas

Advertise

Contact Us

Do Not Sell My Information

Terms and Conditions

Privacy Policy

Dermatology Times and Multimedia Medical, LLC

Twitter

Facebook

Linkedin

Topics

Acne

BPDCN

Hair & Scalp

Rosacea

Skin Cancer (Melanoma)

Skin Cancer (Non-Melanoma)

1rem

View

Perspectives on Advanced Basal Cell Carcinoma

Videos

Is timing everything? Chrysalyne D. Schmults, MD, FAAD looks to a future where clinicians have a better understanding of the “how” and “when” of using hedgehog inhibitors and anti-PD1 medication. Here are the questions she’d like to see answered in upcoming research.

Future Potential for Current Medications 